Booster vaccination using bivalent DS-5670a/b is safe and immunogenic against SARS-CoV-2 variants in children aged 5–11 years: a phase 2/3, randomized, active-controlled study

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2024-09-02
DOI
https://doi.org/10.3389/fimmu.2024.1445459
Citations
5
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
1.95

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Booster vaccination using bivalent DS-5670a/b is safe and immunogenic against SARS-CoV-2 variants in children aged 5–11 years: a phase 2/3, randomized, active-controlled study

Katsuyasu Ishida, Kei Furihata, Miharu Suda, Tetsuo Nakayama et al.
5 citations
Frontiers in Immunology
SARS-CoV-2 and COVID-19 Research
1.95
article

Booster vaccination using bivalent DS-5670a/b is safe and immunogenic against SARS-CoV-2 variants in children aged 5–11 years: a phase 2/3, randomized, active-controlled study

Katsuyasu Ishida, Kei Furihata, Miharu Suda, Tetsuo Nakayama, Kaori Takahashi, Rino Suzuki, Aisaku Ota, Sachiko Sakakibara, Fumihiko Takeshita
article en
5 citations

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 15
Daiichi-Sankyo (Japan) (JP), Kitasato University (JP)
Japan Agency for Medical Research and Development, Ministry of Health, Labour and Welfare, Daiichi Sankyo Europe
Good health and well-being
Openalex Percentile: Top 14%
SARS-CoV-2 and COVID-19 Research
1.95
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.